profit from every $100 of sales.
$0$100
Pheton Holdings
We have no price for Pheton Holdings since 16 March 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$0.32-0.78% today
-54.7% since Oct 10, 25
1-year low $0.321-year high $0.90
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Pheton Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Pheton Holdings | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Pheton Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- 1.1×
- 9.1×
- –
- –
- -19.0%
- -16.2%
- 0.0%
Profitability
- 82.9%
- -831.1%
- -790.6%
- -775.2%
- -52.1%
- -9.1%
- -44.2%
- -47.2%
- -53.6%
- 27.2%
Growth
- −13.9%
- –
- −1,119.2%
- –
- −4.3%
Financial health
- 0.7×
- 0.03
- 2.7%
- –
- 11.69
- 11.36
- 0.06
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 6%of 952
Bottom 7%of 886
Bottom 4%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
67Pass
Philip Fisher
60Pass
Peter Lynch
42No pass
Joel Greenblatt
2No pass
Charlie Munger
65Pass
Terry Smith
60Pass
Questions about Pheton Holdings
Is Pheton Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Pheton Holdings AI analysis
What does Pheton Holdings do?
Pheton Holdings Ltd is a specialized healthcare enterprise focused on the development and commercialization of software and devices integral to brachytherapy treatments. It is in Medical - Devices.
Does Pheton Holdings pay a dividend?
No. Pheton Holdings does not pay a dividend at the moment.
Is Pheton Holdings stock halal?
Yes. Pheton Holdings passes our halal screen: its business is permitted and its debt is 0% of its market value, under the 30% limit. How we check
Who are Pheton Holdings's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Pheton Holdings's.
Prices: daily closes to Mar 16, 2026. Fundamentals: company reports via invest-like data.